NDC 63323-104 – Etoposide
Etoposide 20 mg/mL · Injection, Solution · Intravenous
Product NDC63323-104
Product details
- Brand name
- Etoposide
- Generic name
- Etoposide
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA074983
- Marketed since
- July 18, 2001
- Listing expires
- December 31, 2027
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Etoposide 20 mg/mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 63323-104-05 | 10 BOX in 1 CARTON (63323-104-05) / 1 VIAL, MULTI-DOSE in 1 BOX (63323-104-01) / 5 mL in 1 VIAL, MULTI-DOSE | Jul 18, 2001 |
| 63323-104-06 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-06) / 5 mL in 1 VIAL, MULTI-DOSE | Sep 9, 2022 |
| 63323-104-25 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-25) / 25 mL in 1 VIAL, MULTI-DOSE | Jul 18, 2001 |
| 63323-104-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) / 50 mL in 1 VIAL, MULTI-DOSE | Jul 18, 2001 |
Other Etoposide products
- 16729-114 Etoposide 20 mg/mL · Injection · Accord Healthcare Inc.
- 68001-265 Etoposide 20 mg/mL · Injection · BluePoint Laboratories
- 68001-681 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-682 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-683 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 0143-9376 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9510 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9511 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9512 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 71288-175 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-176 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-177 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.